"A cancer diagnosis can be scary, confusing and overwhelming, whether it’s you or someone you love. At Providence Holy Family Hospital, cancer is never something you go through alone. Our Cancer Services team will guide all aspects of your cancer care, offering the most advanced treatments, promising clinical trials and support services. We recognize the importance of stopping cancer before it starts and catching it early through our screening and prevention programs. From our state-of-the-art diagnostic tools and treatments to our attentive staff who know that a friendly ear and caring touch can often be powerful medicine, we’ll be by your side no matter where you’re at on your cancer journey."

During the past decade, Providence Cancer Center at Holy Family Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Providence Cancer Center at Holy Family Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 7 trials, followed by "SWOG Cancer Research Network" with 4 trials sponsored, "National Cancer Institute (NCI)" with 2 trials sponsored, "Eastern Cooperative Oncology Group" with 1 trials sponsored and "NSABP Foundation Inc" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Cancer Center at Holy Family Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "North Central Cancer Treatment Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Providence Cancer Center at Holy Family Hospital" are "Lung Cancer" (4 trials), "Breast Cancer" (3 trials), "Colorectal Cancer" (2 trials), "Bladder Cancer" (1 trials) and "Head and Neck Cancer" (1 trials). Many other conditions were trialed in "Providence Cancer Center at Holy Family Hospital" in a lesser frequency.

Most popular intervention types in "Providence Cancer Center at Holy Family Hospital" are "Drug" (11 trials), "Biological" (3 trials), "Procedure" (2 trials), "Radiation" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "capecitabine" (2 trials), "cetuximab" (2 trials), "cisplatin" (2 trials), "cyclophosphamide" (2 trials) and "doxorubicin hydrochloride" (2 trials). Other intervention names were less common.

The vast majority of trials in "Providence Cancer Center at Holy Family Hospital" are 12 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Providence Cancer Center at Holy Family Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Providence Cancer Center at Holy Family Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Providence Cancer Center at Holy Family Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".